To connect with a member of the CHASE team, please contact

Richard Grethe joins CHASE as a Non-Executive Director

We are pleased to announce the appointment of Richard Grethe as a Non-Executive Director to CHASE. 

Richard has a rich history and extensive experience in the UK life-sciences industry. He started his career as a Chartered Accountant at KPMG and has worked in Pharmaceuticals for 30 years at Wellcome PLC, Medeva, Celltech, and UCB. 

In 2004, he was a founding member of Focus Pharma and sold it to trade in 2014. Since 2015, Richard has served as CFO and subsequently Non-Executive Director of the market-leading medical animation company Random42.

On joining CHASE Richard said: 

I have arrived at CHASE having been involved in PE-backed Pharma businesses for nearly 20 years.  The knowledge I have is wide, and Graham and the team are a real bunch of people I can get on with and help develop the business going forward. The CHASE team are trusted in the industry, hard-working and innovative in their approach, and adapt to a changing market effortlessly.

Graham Hawthorn, Managing Director of CHASE said: 

We’re delighted that Richard has joined our team. His experience, both client and service side, will be invaluable as we continue to develop the CHASE offering. 

Share this article